Numab

is a Switzerland-based biotechnology company that discovers and develops immuno-oncology therapies for the treatment of cancer...
Read more
Numab CEO: Barbara Angehrn Pavik

CEO

Barbara Angehrn Pavik

CEO Approval Rating

83/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$204M

Numab Competitors

1Alentis
2Araris
3Debiopharm
4Leinco Technologies
5AbCellera
6PanOptica
7Amgen
8Surface Oncology
9Sutro Biopharma
10Morphotek

Trending Companies